PASCAL Precision implant system: 20000IS and 20000ISM PASCAL Precision guide sheath: 20000GS
Edwards Lifesciences, LLC · Decision date Oct 2, 2025
What did the FDA decide?
FDA records P220003/S026 as a supplement to PMA P220003, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 2, 2025.
FDA approval order statement
the addition of a new Ethylene Oxide (EO) Sterilization Line at the existing and approved EO sterilization facility
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 2, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P220003/S026
- Regulatory pathway
- PMA supplement
- Applicant
- Edwards Lifesciences, LLC
- Product code
- NKM
- Decision code
- OK30
- Decision date
- Oct 2, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Mitral valve repair devices.
- Applicant
- Edwards Lifesciences, LLC
- Product code
- NKM
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P220003. Subsequent supplements may change the device or its indications.
FDA decision timeline
P220003 · Original PMA
PASCAL Precision Transcatheter Valve Repair System
P220003/S024 · Related supplement
PASCAL Precision Transcatheter Valve Repair System
P220003/S026 received
Application receipt date recorded by FDA.
P220003/S025 · Related supplement
PASCAL Precision Transcatheter Valve Repair System
P220003/S026 · FDA decision
30-Day Notice
P220003/S027 · Related supplement
PASCAL Precision Transcatheter Valve Repair System
P220003/S030 · Related supplement
PASCAL Precision Transcatheter Valve Repair System
P220003/S031 · Related supplement
PASCAL Precision implant system (20000IS and 20000ISM); PASCAL Precision guide sheath system (20000GS)
P220003/S033 · Related supplement
PASCAL Precision Transcatheter Valve Repair System
P220003/S028 · Related supplement
PASCAL Ace with Capture Clarity Valve Repair System MR Implant System
P220003/S029 · Related supplement
PASCAL Precision Transcatheter Valve Repair System
P220003/S032 · Related supplement
PASCAL Precision Transcatheter Valve Repair System
Timeline entries are records held by MedtechLedger for P220003. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P220003
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA approval | Sep 14, 2022 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Jul 25, 2025 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Sep 9, 2025 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Apr 21, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Jun 18, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Jul 29, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Sep 9, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Sep 23, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 20, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 22, 2026 | FDA |
Explore the linked device profile
Other records with product code NKM
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MitraClip SystemsP100009/S086 | ABBOTT MEDICAL | PMA supplement | Jun 25, 2026 | FDA |
MitraClip Delivery SystemsP100009/S085 | ABBOTT MEDICAL | PMA supplement | May 28, 2026 | FDA |
MitraClip SystemsP100009/S084 | ABBOTT MEDICAL | PMA supplement | May 14, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Mar 6, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Edwards Lifesciences, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- One Edwards Way, Irvine, CA, 92614
Sources and methodology
- Original FDA record: P220003/S026
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



